Universe Pharmaceuticals INC — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a2e212fb-8ffb-4eaa-8659-d87935ea83c7/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-2.9B | 2024-10-01 – 2025-09-30 | evidence 0001213900-26-009000 |
| FY 2024 | $-8.0B | 2023-10-01 – 2024-09-30 | evidence 0001213900-26-009000 |
| FY 2023 | $-4.0B | 2022-10-01 – 2023-09-30 | evidence 0001213900-26-009000 |
| FY 2022 | $-7.0M | 2021-10-01 – 2022-09-30 | evidence 0001213900-25-036798 |
| FY 2021 | $13.6M | 2020-10-01 – 2021-09-30 | evidence 0001213900-22-004359 |
| FY 2020 | $10.3M | 2019-10-01 – 2020-09-30 | evidence 0001213900-22-004359 |
| FY 2019 | $9.8M | 2018-10-01 – 2019-09-30 | evidence 0001213900-22-004359 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Universe Pharmaceuticals INC — all facts · Revenue · Net Income